| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/27/2001 | WO2001070708A1 Substituted piperidines as melanocortin receptor agonists |
| 09/27/2001 | WO2001070706A2 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
| 09/27/2001 | WO2001070702A1 6-hydroxy-indazole derivatives for treating glaucoma |
| 09/27/2001 | WO2001070701A1 5-hydroxy indazole derivatives for treating glaucoma |
| 09/27/2001 | WO2001070700A1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 09/27/2001 | WO2001070698A1 Quinoline derivatives and medicinal use thereof |
| 09/27/2001 | WO2001070696A1 Nitroethenamine derivatives or salts thereof and pharmaceutical compositions containing the derivatives or the salts |
| 09/27/2001 | WO2001070695A1 Pyridine derivatives as inhibitors of p38 |
| 09/27/2001 | WO2001070694A1 Amorphous torasemide modification |
| 09/27/2001 | WO2001070693A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 09/27/2001 | WO2001070691A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | WO2001070690A1 Heterocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | WO2001070683A2 3-substituted-4-pyrimidone derivatives |
| 09/27/2001 | WO2001070682A2 Carbocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | WO2001070677A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 09/27/2001 | WO2001070676A1 Sponge antitumor compounds |
| 09/27/2001 | WO2001070675A2 Inhibitors of histone deacetylase |
| 09/27/2001 | WO2001070674A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 09/27/2001 | WO2001070673A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 09/27/2001 | WO2001070672A2 Compounds and methods to treat alzheimer's disease |
| 09/27/2001 | WO2001070668A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 09/27/2001 | WO2001070664A2 Lipoxin analogs and methods for the treatment of periodontal disease |
| 09/27/2001 | WO2001070662A2 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 09/27/2001 | WO2001070591A1 Infusion packet with useful and decorative elements, support member, delivery system and method |
| 09/27/2001 | WO2001070577A1 Methods of producing a terminally sterilized topical patch preparation |
| 09/27/2001 | WO2001070337A1 Spiropiperidine derivatives as melanocortin receptor agonists |
| 09/27/2001 | WO2001070320A1 Methods and systems for enhancing fluid flow through an obstructed vascular site |
| 09/27/2001 | WO2001070259A1 Improvements in and relating to digestive/laxative compositions |
| 09/27/2001 | WO2001070258A1 Pharmaceutical composition of carrier substance for products based on vitamin-e, bromeline and hyaluronidase |
| 09/27/2001 | WO2001070255A2 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 09/27/2001 | WO2001070251A1 Anticancer compositions |
| 09/27/2001 | WO2001070249A1 Cosmetic use of hop and ornithine |
| 09/27/2001 | WO2001070248A1 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress |
| 09/27/2001 | WO2001070240A1 Use of alkylammonium salts as protein crystallization reagents |
| 09/27/2001 | WO2001070239A1 Use of azithromycin for infections with leishmania |
| 09/27/2001 | WO2001070238A1 Creatine containing caramel |
| 09/27/2001 | WO2001070236A1 Preventing and/or treating diabetes mellitus |
| 09/27/2001 | WO2001070234A1 Anaesthetic composition |
| 09/27/2001 | WO2001070233A2 Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof |
| 09/27/2001 | WO2001070232A1 Protease inhibitors |
| 09/27/2001 | WO2001070231A2 Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuries |
| 09/27/2001 | WO2001070230A2 Compounds with 5-ht activity useful for controlling visual field loss |
| 09/27/2001 | WO2001070229A1 Thrombin inhibitors |
| 09/27/2001 | WO2001070226A1 Novel processes for preparing torsemide intermediate |
| 09/27/2001 | WO2001070225A2 Oxazolidinone tablet formulation |
| 09/27/2001 | WO2001070224A2 Rilmenidine dressing and method for preparing same |
| 09/27/2001 | WO2001070223A1 Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma |
| 09/27/2001 | WO2001070222A2 Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| 09/27/2001 | WO2001070220A1 A method of administering liposomal encapsulated taxane |
| 09/27/2001 | WO2001070218A1 Method for treating congestive heart failure |
| 09/27/2001 | WO2001070217A1 Dna-cleaving antitumor agents |
| 09/27/2001 | WO2001070216A2 Diphenyl ketoaldehyde derivatives with anti-hiv activity |
| 09/27/2001 | WO2001070215A1 Bactericidal preparation |
| 09/27/2001 | WO2001070214A2 The use of cocoa procyanidins combined with acetylsalicyclic acid as an anti-platelet therapy |
| 09/27/2001 | WO2001070213A2 Bactericidal antimicrobial methods and compositions for use in treating gram positive infections comprising an antibiotic potentiator having acyl hydrazide oxy amide or 8-hydroxy quinoline structure |
| 09/27/2001 | WO2001070212A2 Method and composition for preventing or reducing the symptoms of menopause |
| 09/27/2001 | WO2001070211A2 L-arginine and phosphodiesterase (pde) inhibitor synergism |
| 09/27/2001 | WO2001070210A2 Methods for improving size and appearance of a wound |
| 09/27/2001 | WO2001070209A2 Mono- and disaccharides for the treatment of nitric oxide related disorders |
| 09/27/2001 | WO2001070208A2 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 09/27/2001 | WO2001070207A2 5ht2 agonists for controlling iop and treating glaucoma |
| 09/27/2001 | WO2001070206A2 Combination of lecithin with ascorbic acid |
| 09/27/2001 | WO2001070205A2 Composition comprising paracetamol and niflumic acid |
| 09/27/2001 | WO2001070204A2 Highly selective inhibitors of the urokinase plasminogen activator |
| 09/27/2001 | WO2001070203A2 Agent for treating hepatitis c containing ukrain |
| 09/27/2001 | WO2001070199A1 Matrices containing nitric oxide donors and reducing agents and their use |
| 09/27/2001 | WO2001070198A1 Stabilized dry powder formulations |
| 09/27/2001 | WO2001070176A2 Use of 3,4-dihydroxy-mandelic acid for protecting against oxidative damage caused by ultra-violet light |
| 09/27/2001 | WO2001070172A2 Solid, water-dispersible, oral pharmaceutical form comprising rifampicin, isoniazid and pyridoxine hydrochloride, method for obtaining and presenting said pharmaceutical form |
| 09/27/2001 | WO2001070170A1 Container for linezolid intravenous solution |
| 09/27/2001 | WO2001070154A1 Device and method for treating urinary incontinence in females |
| 09/27/2001 | WO2001070093A2 Agents and methods for the prevention of initial onset of cancers, the treatment of cancers, and the recurrence of existing cancers |
| 09/27/2001 | WO2001070046A1 Natural vegetable oil concentrated in unsaponifiable matters as food ingredient |
| 09/27/2001 | WO2001070031A1 Opioid growth factor modulates angiogenesis |
| 09/27/2001 | WO2001070029A1 Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones |
| 09/27/2001 | WO2001062705A8 Aminoalcohol derivatives |
| 09/27/2001 | WO2001062234A8 Dosing regimen |
| 09/27/2001 | WO2001060822A8 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 09/27/2001 | WO2001032663A3 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 09/27/2001 | WO2001032654A3 Novel heterocyclic compounds and their use as medicines |
| 09/27/2001 | WO2001019901A3 Process for making aqueous coated beadlets |
| 09/27/2001 | WO2001019829A3 Pyrazolopyrimidines as therapeutic agents |
| 09/27/2001 | WO2001019824A3 New active marine alkaloids |
| 09/27/2001 | WO2001019794A3 Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |
| 09/27/2001 | WO2001019386A3 Composition for stabilizing corneal tissue during or after orthokeratology lens wear |
| 09/27/2001 | WO2001019320A3 Phospholipid prodrugs of anti-proliferative drugs |
| 09/27/2001 | WO2001018546A3 Screening for inhibitors of 'paired helical filaments' |
| 09/27/2001 | WO2001016170A3 Card proteins involved in cell death regulation |
| 09/27/2001 | WO2001015684A3 Antimycotic drug |
| 09/27/2001 | WO2001014576B1 Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
| 09/27/2001 | WO2001013895A3 Controlled-release sedative-hypnotic compositions and methods related thereto |
| 09/27/2001 | WO2001012606B1 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 09/27/2001 | WO2001008637A3 Treatment of premenstrual syndrome and menopause |
| 09/27/2001 | WO2001007019A3 Use of n-acetyl-cysteine in the treatment of allergic pathologies of the respiratory tract |
| 09/27/2001 | WO2001004134A3 Novel esters derived from nucleosides, preparation methods and pharmaceutical compositions containing them |
| 09/27/2001 | WO2001001968A3 Methods and compositions for regulating gut motility and food intake |
| 09/27/2001 | WO2001000665A3 Inhibitors of memapsin 2 and use thereof |
| 09/27/2001 | WO2000078275A3 Antibacterial compositions |
| 09/27/2001 | WO2000074664A3 Novel iron chelators and pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders |
| 09/27/2001 | WO2000061541A3 Pharmaceutical compounds |